+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 53 Pages
  • June 2023
  • GlobalData
  • Novan Inc.
  • ID: 4395061
Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novan Inc (Novan) is a clinical-stage biotechnology company that focuses on leveraging nitric oxide's immunomodulatory and anti-microbial mechanisms of action for the treatment of various skin diseases. The company's products find application in the treatment of dermatology disorders, gastroenterology and women's health. Its pipeline products focus on treating acne vulgaris, external genital warts, onychomycosis, psoriasis, molluscum, tinea pedis, human papillomavirus (HPV) and atopic dermatitis. Novan uses its proprietary technology Nitricil to develop new chemical entities with sustained delivery of nitric oxide. It works in collaboration with academic institutions, universities, private and public companies. Novan is headquartered in Durham, North Carolina, the US.

Novan Inc Key Recent Developments

  • Jun 16, 2023: Novan Announces Board Changes
  • Jun 05, 2023: Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
  • May 31, 2023: Novan focuses strategic direction and announces restructuring
  • May 08, 2023: Novan to report first quarter 2023 financial results on May 15, 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Novan Inc - Key Facts
  • Novan Inc - Key Employees
  • Novan Inc - Key Employee Biographies
  • Novan Inc - Major Products and Services
  • Novan Inc - History
  • Novan Inc - Company Statement
  • Novan Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Novan Inc - Business Description
  • Business Segment: Commercial Operations
  • Overview
  • Performance
  • Business Segment: Research and Development Operations
  • Overview
  • Performance
  • R&D Overview
  • Novan Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Novan Inc - Strengths
  • Novan Inc - Weaknesses
  • Novan Inc - Opportunities
  • Novan Inc - Threats
  • Novan Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Novan Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 16, 2023: Novan Announces Board Changes
  • Jun 05, 2023: Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
  • May 31, 2023: Novan focuses strategic direction and announces restructuring
  • May 08, 2023: Novan to report first quarter 2023 financial results on May 15, 2023
  • Mar 23, 2023: Novan to Report Full Year 2022 Financial Results on March 30, 2023
  • Nov 14, 2022: Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
  • Nov 07, 2022: Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
  • Oct 14, 2022: Novan and EPI Health, a Novan Company, announce abstracts accepted for poster presentation at the 42nd Annual Fall Clinical Dermatology Conference
  • Aug 11, 2022: Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update
  • Aug 04, 2022: Novan to Report Second Quarter 2022 Financial Results on August 11, 2022
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Novan Inc, Key Facts
  • Novan Inc, Key Employees
  • Novan Inc, Key Employee Biographies
  • Novan Inc, Major Products and Services
  • Novan Inc, History
  • Novan Inc, Subsidiaries
  • Novan Inc, Key Competitors
  • Novan Inc, Ratios based on current share price
  • Novan Inc, Annual Ratios
  • Novan Inc, Interim Ratios
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Novan Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Novan Inc, Performance Chart (2018 - 2022)
  • Novan Inc, Ratio Charts
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Novan Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Dermavant Sciences Inc
  • Sol-Gel Technologies Ltd
  • Arcutis Biotherapeutics Inc
  • Leo Pharma AS
  • Sun Pharmaceuticals, LLC
  • Verrica Pharmaceuticals Inc
  • Galderma Laboratories LP
  • Almirall SA
  • Journey Medical Corp
  • Mayne Pharma USA Inc
  • Ortho Dermatologics Inc